Search for: "Barr Laboratories" Results 1 - 20 of 373
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2014, 9:59 pm by Patent Docs
Noonan -- In ANDA litigation between branded drug maker Alcon Research and generic drugmaker Barr Laboratories, the Federal Circuit affirmed a District Court finding of non-infringement and reversed a finding of invalidity for failure to satisfy either the enablement or written description requirements of 35 U.S.C. [read post]
3 Aug 2011, 9:55 pm by Patent Docs
By Donald Zuhn -- Yesterday, the Federal Circuit affirmed a decision by the District Court for the Southern District of New York finding that Defendants-Appellants Barr Laboratories, Inc. and Pliva-Hrvatska d.o.o. [read post]
16 Nov 2010, 9:59 pm by Patent Docs
Barr Laboratories, Inc., the Federal Circuit reversed the decision by the District Court for the District of Delaware holding U.S. [read post]
17 Aug 2009, 8:01 am
Barr Laboratories (Barr) recalled lot #311756 of the powerful psychostimulant, indicating that consumers might receive exceedingly potent dosages due to oversized tablets. [read post]
17 Aug 2009, 8:01 am
Barr Laboratories (Barr) recalled lot #311756 of the powerful psychostimulant, indicating that consumers might receive exceedingly potent dosages due to oversized tablets. [read post]
14 Jan 2009, 7:07 am
FDANews reported on 14 Jan 09: Medicis Pharmaceutical has received notice that Barr Laboratories has filed an ANDA to market a generic version of Medicis' once-daily, oral acne treatment Solodyn â€â [read post]
22 Jul 2008, 3:36 am
Barr Pharmaceuticals, Inc., a holding company, operates through subsidiaries Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc., and PLIVA d.d. and its subsidiaries. [read post]
31 Oct 2011, 5:46 pm
San Diego - The United States Supreme Court denied Barr Laboratories writ of certiorari on October 31, 2011 in Barr Laboratories v. [read post]
7 Feb 2007, 1:10 pm
District Court for the District of Columbia recently denied Barr Laboratories' motion to dismiss a Federal Trade Commission lawsuit stemming from Barr's agreement with Warner Chilcott concerning generic Ovcon 35. [read post]
10 May 2010, 9:34 pm by Patent Docs
By James DeGiulio -- Celgene and Novartis Reach Settlement with Barr Laboratories in Ritalin ANDA Suit Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over Barr's attempt to market a generic version of the ADHD drug Ritalin. [read post]
3 Jun 2010, 9:36 pm by Patent Docs
By James DeGiulio -- Celgene, Barr Resolve Patent Dispute over Generic Thalomid Celgene Corp. and Barr Laboratories Inc. have resolved their patent dispute over the multiple myeloma cancer drug Thalomid, with Celgene agreeing to drop its patent infringement claims and Barr dropping its invalidity and antitrust claims. [read post]
20 Aug 2009, 8:54 am
Barr Laboratories is recalling one lot of its generic Adderall due to a serious manufacturing defect, the Los Angeles Times reported Aug. 14. [read post]
28 Jan 2010, 9:43 am by Guest Barista
  Cancer Research Technology et al. v Barr Laboratories et al., D-Del, Civ. [read post]
23 Oct 2006, 6:10 pm
  The FTC filed the case to nullify a reverse payment agreement between Warner Chilcott and Barr Laboratories that would have prevented Barr from launching a generic version of Ovcon 35 until May, 2009. [read post]
11 Oct 2009, 9:04 pm
.; Barr Laboratories Inc.; Barr Pharmaceuticals Inc.; Barr Pharmaceuticals, LLC; Teva Pharmaceuticals Industries Ltd.; Teva Pharmaceuticals USA Inc. [read post]
22 Sep 2011, 9:55 pm by Patent Docs
In May 2009, Allergan filed the suit in the District of Delaware against Teva and Barr Laboratories, alleging infringement of U.S. [read post]
11 Nov 2007, 6:51 pm
Barr Laboratories Inc. 1:07-cv-00718; filed November 7, 2007 in the District Court of... [read post]
30 Jul 2023, 7:08 pm by Jenny Schell
   Samples were collected from the cases according to the technical health standard for epidemiological surveillance and laboratory diagnosis of GBS in Peru. [read post]